Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)

INTRODUCTION: Cyclooxygenase 2 (COX-2) inhibitors have less upper gastrointestinal toxicity than traditional non-steroidal anti-inflammatory drugs (NSAIDs). However, both COX-2 inhibitors and traditional NSAIDs may be associated with adverse cardiovascular side effects. Data from randomised and obse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: MacDonald, Thomas M, Mackenzie, Isla S, Wei, Li, Hawkey, Christopher J, Ford, Ian
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2013
Matèries:
Pharmacology and Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563118/
https://ncbi.nlm.nih.gov/pubmed/23364320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-002295
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars